Skip to main navigation Skip to search Skip to main content

A Phase 1 Dose Escalation and Phase 2 Randomized, Placebo-Controlled Study of the Efficacy and Tolerability of Veliparib in Combination with Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Viliparib and . . .

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date12/3/14 → 12/2/20

Funding

  • AbbVie Incorporated: $126,632.50